Alx oncology enters $100 million loan facility agreement with oxford finance and silicon valley bank to support ongoing development of evorpacept

Expects to extend cash runway to mid-2025 expects to extend cash runway to mid-2025
ALXO Ratings Summary
ALXO Quant Ranking